| | |

Can Yogurt and Fiber Reduce Mesothelioma Risk?

reduce mesothelioma risk

The findings of a new lung cancer study suggest that eating yogurt and fiber might help reduce mesothelioma risk. 

The study in JAMA Oncology involved more than 1.4 lung cancer patients from around the world. 

Researchers assessed the results of 10 dietary studies between 2017 and 2019. They found a “synergistic association” between eating fiber and yogurt and a lower risk of lung cancer. 

Pleural mesothelioma is a lung-related cancer with many of the same characteristics as lung cancer. It is possible that the same dietary habits might reduce mesothelioma risk, too. 

The Yin and Yang of an Anti-Cancer Diet

The lung cancer researchers did not choose to study yogurt and fiber randomly. Dietary fiber is the main source of prebiotics. Yogurt contains probiotics. 

Together, these two foods help balance the gut microbiome. There is evidence that a good balance of bacteria in the gut may help ward off cancer by reducing inflammation. 

Malignant mesothelioma is strongly linked to inflammation. The idea that a balanced microbiome could reduce mesothelioma risk or lung cancer incidence has not been well-studied. The goal of this study was to see if the two are linked.  

Eating to Reduce Mesothelioma Risk

The best way to reduce mesothelioma risk is to avoid any exposure to asbestos. Any level of asbestos exposure can raise the odds of contracting malignant mesothelioma even decades later. 

People with asbestos exposure in their background have to be especially diligent about diet and lifestyle. Smoking, for instance, can raise the odds of eventually receiving a mesothelioma diagnosis.

The longest-living mesothelioma patients eat a diet rich in fruits, vegetables, and lean protein and avoid smoking. But the new findings indicate that even smokers might reduce their mesothelioma risk with yogurt and fiber.

Cancer Risk, Yogurt, and Fiber

Out of the 1.4 million people studied, 18,882 either had or developed lung cancer over the course of 8 years. Researchers compared how much fiber and yogurt these people ate to see what role it might have played in their cancer. 

People in the top fifth of fiber-eaters had a 17 percent lower risk of lung cancer compared to people in the bottom fifth. People who ate an average of three to four ounces of yogurt a day were 19 percent less likely to get lung cancer than non-yogurt eaters. 

But the most important news for people wishing to reduce mesothelioma risk came from those who ate the highest levels of both yogurt and fiber. These patients reduced their risk for lung cancer by more than 30 percent. This risk was lower even among people who had smoked.

“Our findings suggest a potential protective role of prebiotics and probiotics against lung carcinogenesis [cancer development],” writes senior author Dr. Xiao-Ou Shu of Vanderbilt University.

Source:

Yang, JJ, et al, “Association of Dietary Fiber and Yogurt Consumption With Lung Cancer Risk”, October 24, 2019, JAMA Oncology, https://jamanetwork.com/journals/jamaoncology/article-abstract/2753175

Similar Posts

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…

  • |

    Chemical in Wine May Improve Mesothelioma Treatment

    There’s new evidence that a compound found in red wine may help improve the effectiveness of chemotherapy treatment for malignant pleural mesothelioma. Last year, a team of Korean researchers released the world’s first study on the mesothelioma-fighting power of resveratrol, a natural phenol derived from the skin of red grapes and found in red wine and grape juice. Now, the same team says resveratrol also appears to enhance the chemosensitivity of malignant mesothelioma cells. Study author Yoon-Jin Lee and colleagues discovered  a synergistic cancer-fighting effect in mesothelioma cells treated with both resveratrol and clofarabine, a prescription drug often used to treat acute lymphoblastic leukemia. Together, resveratrol and clofarabine “induced a strong cytotoxic effect” by influencing levels of the tumor suppressor,…

  • | |

    Micro-RNAs May Offer New Way to Fight Mesothelioma

    Scientists at one of the world’s top mesothelioma research centers, the Asbestos Diseases Research institute in Sydney, Australia, say that restoring the expression of certain micro RNAs in the cells of mesothelioma patients may offer a new way to fight the disease. A microRNA is a small RNA molecule which is involved in the regulation of gene expression. According to a new report in the Annals of Oncology, the Australian scientists found reduced expression of the micro RNA-15 family (miR-15/16) in the cells of mice with mesothelioma. “When malignant pleural mesothelioma cell lines were compared with the normal mesothelial cell line MeT-5A, the downregulation of miR-15/16 was 2- to 10-fold,” they report. This finding is consistent with previous cancer research…

  • | |

    Treatment Uses Herpes Virus to Shrink Mesothelioma Tumors

    Researchers at a hospital in Sheffield, England are testing a potential new mesothelioma treatment based on the same virus that causes herpes. The small-scale trial is the first in the world to test the modified herpes simplex virus, HSV1716, in human mesothelioma patients. HSV1716 has been genetically engineered to infect and kill cancer cells without harming healthy cells. In laboratory studies on mesothelioma and some other cancers, it has been shown to be effective at shrinking tumors while causing limited toxicity. Just as significantly, HSV1716 increased survival rates among mice with various human cancers. The Phase I/II trial at Sheffield Experimental Cancer Medicine Centre is the next stage in development of HSV1716 as a viable mesothelioma treatment. The goal of…

  • | |

    New Mesothelioma Drug Kills Cancer Stem Cells

    Citing “significant enthusiasm within the mesothelioma community”, the manufacturers of a promising new mesothelioma drug say they have begun a major test of the drug in patients. Massachusetts-based Verastem, Inc. focuses on drugs that fight cancer by attacking the stem cells that give rise to them. Earlier this summer, the FDA granted orphan drug status to their stem cell inhibitor, defactinib, for the treatment of mesothelioma. The designation, which is reserved for drugs that fight the rarest of diseases, helps pave the way for testing and faster approval, depending on the results of clinical trials. “Development of a drug that preferentially kills cancer stem cells is a promising approach, as many standard-of-care treatments have been shown to either have no…

  • | |

    Mesothelioma Study Finds New Treatment Target

    Immunotherapy, which involves reprogramming T-cells to find and attack cancer cells, is one of the fastest-growing areas of cancer research. One of the biggest challenges of immunotherapy is how to harness the power of T-cells against cancer without also turning them against healthy cells. A new study conducted in Switzerland and published in the Journal of Translational Medicine addressed the problem by reprogramming T-cells to recognize and attack mesothelioma cells that express a specific protein. Fibroblast Activation Protein (FAP) is expressed on the surface of tumor-associated fibroblast cells which are found in the connective tissue of mesothelioma tumors. FAP is also found in mesothelioma cells and may play a role in the start of cancer, as well as the growth…